AbCellera Biologics Inc (NASDAQ:ABCL) currently has a daily average trading volume of 6.03M but it saw 5700718 shares traded in last market. With a market cap of 1.50B USD, the company’s current market price of $5.02 came rising about 0.60 while comparing to the previous closing price of $4.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.82 and as low as $1.89. In the recent trading on the day, stock has struck highest price mark of $4.96 while lowest mark touched by it was $5.35.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which resumed the stock as “Outperform” in its note to investors issued on July 07, 2025, recommending a price target of $5 for it. The Benchmark Company issued its recommendations for the stock as it upgraded the price target for the stock is $9.
Over the week, ABCL’s stock price is moving 28.72% up while it is 36.41% when we observe its performance for the past one month. Year-to-date it is 66.78% up and over the past year, the stock is showing an upside performance of 71.33%.
Currently, AbCellera Biologics Inc’s total number of outstanding shares is 298.36M. Company’s return on investment (ROI) stands at -15.45% and return on equity (ROE) at -15.59%. Stock’s beta reads 0.68. Stock has a price to book (P/B) ratio of 1.46 while price to sale or P/S ratio amounts to 64.81. Its return on asset (ROA) is -11.96% on average.
